Hypha Labs, Inc. Files 2024 10-K

TL;DR

Hypha Labs (formerly Digipath) filed its 2024 10-K. Check financials for 9/30/24.

AI Summary

Hypha Labs, Inc. filed its 10-K for the fiscal year ending September 30, 2024, reporting on its operations as a testing laboratory. The company, formerly known as Digipath, Inc., is incorporated in Nevada and headquartered in Las Vegas. The filing covers the period up to January 13, 2025, and includes financial data for the fiscal years 2023 and 2024.

Why It Matters

This filing provides a comprehensive overview of Hypha Labs' financial health and operational status for the past fiscal year, which is crucial for investors and stakeholders to assess the company's performance and future prospects.

Risk Assessment

Risk Level: medium — As a 10-K filing, it inherently contains detailed financial and operational information that can reveal significant risks, and the company's history of name changes suggests potential past restructuring or challenges.

Key Numbers

• 20240930 — Fiscal Year End (The end date for the reporting period covered by the 10-K.)
• 20250113 — Filing Date (The date the 10-K was officially submitted to the SEC.)
• 2023-09-30 — Prior Fiscal Year End (The end date of the previous fiscal year, used for comparative financial analysis.)

Key Players & Entities

• Hypha Labs, Inc. (company) — Filer of the 10-K
• Digipath, Inc. (company) — Former name of Hypha Labs, Inc.
• 20240930 (date) — Fiscal year end
• 20250113 (date) — Filing date
• Las Vegas (location) — Company headquarters
• Nevada (location) — State of incorporation

FAQ

Key Financial Figures

• $0.022 — istrant based upon the closing price of $0.022 per share as of March 31, 2024 was appr
• $34.75 billion — tional mushrooms was estimated to be at $34.75 billion in 2024, and is projected to grow to $6
• $65.83 billion — on in 2024, and is projected to grow to $65.83 billion by 2030 with a CAGR of 11.2% (Source: G

Filing Documents

• form10-k.htm (10-K) — 1626KB
• ex4-7.htm (EX-4.7) — 34KB
• ex31-1.htm (EX-31.1) — 14KB
• ex32-1.htm (EX-32.1) — 7KB
• form10-k_001.jpg (GRAPHIC) — 13KB
• form10-k_002.jpg (GRAPHIC) — 3KB
• 0001493152-25-001966.txt ( ) — 7951KB
• funi-20240930.xsd (EX-101.SCH) — 61KB
• funi-20240930_cal.xml (EX-101.CAL) — 88KB
• funi-20240930_def.xml (EX-101.DEF) — 255KB
• funi-20240930_lab.xml (EX-101.LAB) — 547KB
• funi-20240930_pre.xml (EX-101.PRE) — 438KB
• form10-k_htm.xml (XML) — 1071KB

Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 48

Controls and Procedures

Item 9A. Controls and Procedures 48

Other Information

Item 9B. Other Information 49

Disclosure Regarding Foreign Jurisdictions that Prevent Inspections

Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections 49 PART III

Directors, Executive Officers and Corporate Governance

Item 10. Directors, Executive Officers and Corporate Governance 49

Executive Compensation

Item 11. Executive Compensation 50

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 52

Certain Relationships and Related Transactions, and Director Independence

Item 13. Certain Relationships and Related Transactions, and Director Independence 52

Principal Accounting Fees and Services

Item 14. Principal Accounting Fees and Services 53 PART IV

Exhibits and Financial Statement Schedules

Item 15. Exhibits and Financial Statement Schedules 53

Form 10-K Summary

Item 16. Form 10-K Summary 55

SIGNATURES

SIGNATURES 56 PART I Forward Looking Statements This Form 10-K contains "forward-looking" statements including statements regarding our expectations of our future operations. For this purpose, any statements contained in this Form 10-K that are not statements of historical fact may be deemed to be forward-looking "anticipate," "estimate," or "continue" or comparable terminology are intended to identify forward-looking on a variety of factors, many of which are not within our control. Although the forward-looking statements in this Form 10-K reflect the good faith judgment of our management, such statements can only be based on facts and factors currently known by them. These risks and uncertainties include: the successful development of our products; the demand for our products; our ability to obtain and maintain customer relationships; the impact of competitive products; our ability to market and grow demand for our products; our ability to obtain additional financing to launch our business and execute our business strategy; general economic and market conditions and consumer discretionary spending; our ability to manage our growth; our ability to protect our internal information technology system against security breaches, loss or leakage of data and other disruptions; our reliance on third party manufacturers who may be based outside the United States; our ability to protect our intellectual property; and our reliance on key individuals and our ability to attract and retain qualified personal. These and other risks are described under the heading "Risk Factors" in this Form 10-K. In light of these risks and uncertainties, you are cautioned not to place undue reliance on these forward-looking statements. Except as required

View Full Filing

View this 10-K filing on SEC EDGAR